Association Between Preapproval Confirmatory Trial Initiation and Conversion to Traditional Approval or Withdrawal in the FDA Accelerated Approval Pathway
Shahzad, Mahnum, Naci, Huseyin, Wagner, Anita K
Published in JAMA : the journal of the American Medical Association (07.03.2023)
Published in JAMA : the journal of the American Medical Association (07.03.2023)
Get full text
Journal Article
Newly approved cancer drugs in China - innovation and clinical benefit
Zhang, Yichen, Wagner, Anita K, Guan, Xiaodong
Published in Nature reviews. Clinical oncology (01.03.2023)
Published in Nature reviews. Clinical oncology (01.03.2023)
Get full text
Journal Article
Overall survival benefits of cancer drugs initially approved by the US Food and Drug Administration on the basis of immature survival data: a retrospective analysis
Naci, Huseyin, Zhang, Yichen, Woloshin, Steven, Guan, Xiaodong, Xu, Ziyue, Wagner, Anita K
Published in The lancet oncology (01.06.2024)
Published in The lancet oncology (01.06.2024)
Get full text
Journal Article
Essential medicines for universal health coverage
Wirtz, Veronika J, Dr, Hogerzeil, Hans V, Prof, Gray, Andrew L, MSc, Bigdeli, Maryam, PhD, de Joncheere, Cornelis P, PharmD, Ewen, Margaret A, Dip Pharm, Gyansa-Lutterodt, Martha, MA, Jing, Sun, PhD, Luiza, Vera L, PhD, Mbindyo, Regina M, MBA, Möller, Helene, PhD, Moucheraud, Corrina, ScD, Pécoul, Bernard, MPH, Rägo, Lembit, PhD, Rashidian, Arash, Prof, Ross-Degnan, Dennis, ScD, Stephens, Peter N, PhD, Teerawattananon, Yot, PhD, t Hoen, Ellen F M, LLM, Wagner, Anita K, PhD, Yadav, Prashant, PhD, Reich, Michael R, Prof
Published in The Lancet (British edition) (28.01.2017)
Published in The Lancet (British edition) (28.01.2017)
Get full text
Journal Article
Communication of Survival Data in US Food and Drug Administration-Approved Labeling of Cancer Drugs
Naci, Huseyin, Guan, Xiaodong, Woloshin, Steven, Xu, Ziyue, Wagner, Anita K
Published in JAMA internal medicine (01.11.2021)
Published in JAMA internal medicine (01.11.2021)
Get more information
Journal Article
Efficacy and costs of spinal muscular atrophy drugs
Darrow, Jonathan J, Sharma, Monica, Shroff, Mansa, Wagner, Anita K
Published in Science translational medicine (11.11.2020)
Published in Science translational medicine (11.11.2020)
Get more information
Journal Article
The impact of speech type on listening effort and intelligibility for native and non-native listeners
Simantiraki, Olympia, Wagner, Anita E., Cooke, Martin
Published in Frontiers in neuroscience (28.09.2023)
Published in Frontiers in neuroscience (28.09.2023)
Get full text
Journal Article
Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment
Wharam, J Frank, Zhang, Fang, Lu, Christine Y, Wagner, Anita K, Nekhlyudov, Larissa, Earle, Craig C, Soumerai, Stephen B, Ross-Degnan, Dennis
Published in Journal of clinical oncology (10.04.2018)
Published in Journal of clinical oncology (10.04.2018)
Get full text
Journal Article
Childhood cancer drugs in China: An overview and comparison of regulatory approvals in China and the United States
Zhang, Yichen, Wagner, Anita, Du, Haoxin, Han, Taisen, Gupta, Sumit, Denburg, Avram E., Frazier, A. Lindsay, Guan, Xiaodong, Shi, Luwen
Published in International journal of cancer (01.02.2022)
Published in International journal of cancer (01.02.2022)
Get full text
Journal Article
Policies and programs to facilitate access to targeted cancer therapies in Thailand
Sruamsiri, Rosarin, Ross-Degnan, Dennis, Lu, Christine Y, Chaiyakunapruk, Nathorn, Wagner, Anita K
Published in PloS one (23.03.2015)
Published in PloS one (23.03.2015)
Get full text
Journal Article
Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018
Fu, Mengyuan, Naci, Huseyin, Booth, Christopher M, Gyawali, Bishal, Cosgrove, Austin, Toh, Sengwee, Xu, Ziyue, Guan, Xiaodong, Ross-Degnan, Dennis, Wagner, Anita K
Published in JAMA internal medicine (01.12.2021)
Published in JAMA internal medicine (01.12.2021)
Get more information
Journal Article
Financial Toxicity of Withdrawn Poly (Adenosine Diphosphate Ribose) Polymerase Inhibitor Indications for Ovarian Cancer
Dottino, Joseph A., Esselen, Katharine M., Costa, Rebecca, Argetsinger, Stephanie, Shahzad, Mahnum, Ross-Degnan, Dennis, Wagner, Anita K.
Published in Value in health (01.09.2024)
Published in Value in health (01.09.2024)
Get full text
Journal Article
Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe
Davis, Courtney, Wagner, Anita K, Salcher-Konrad, Maximilian, Scowcroft, Henry, Mintzes, Barbara, Pokorny, Adrian M J, Lew, Jianhui, Naci, Huseyin
Published in BMJ (Online) (29.03.2023)
Published in BMJ (Online) (29.03.2023)
Get full text
Journal Article
Quality use of medicines within universal health coverage: challenges and opportunities
Wagner, Anita K, Quick, Jonathan D, Ross-Degnan, Dennis
Published in BMC health services research (27.08.2014)
Published in BMC health services research (27.08.2014)
Get full text
Journal Article